Show simple item record

Files in this item


Item metadata

dc.contributor.authorBossé, Janine T
dc.contributor.authorChaudhuri, Roy R.
dc.contributor.authorLi, Yanwen
dc.contributor.authorLeanse, Leon G.
dc.contributor.authorFernandez Crespo, Roberto
dc.contributor.authorCoupland, Paul
dc.contributor.authorHolden, Matthew T G
dc.contributor.authorBazzolli, Denise M.
dc.contributor.authorMaskell, Duncan J.
dc.contributor.authorTucker, Alexander W.
dc.contributor.authorWren, Brendan W.
dc.contributor.authorRycroft, Andrew N.
dc.contributor.authorLangford, Paul R.
dc.contributor.authorBRaDP1T Consortium
dc.identifier.citationBossé , J T , Chaudhuri , R R , Li , Y , Leanse , L G , Fernandez Crespo , R , Coupland , P , Holden , M T G , Bazzolli , D M , Maskell , D J , Tucker , A W , Wren , B W , Rycroft , A N , Langford , P R & BRaDP1T Consortium 2016 , ' Complete genome sequence of MIDG2331, a genetically tractable serovar 8 clinical isolate of Actinobacillus pleuropneumoniae ' , Genome Announcements , vol. 4 , no. 1 , e01667-15 .
dc.identifier.otherPURE: 240890333
dc.identifier.otherPURE UUID: b96c47ad-ff04-45f9-8b9c-e6b642fc1505
dc.identifier.otherPubMed: 26823596
dc.identifier.otherScopus: 85009986574
dc.identifier.otherORCID: /0000-0002-4958-2166/work/60196388
dc.identifier.otherWOS: 000460649500140
dc.descriptionWellcome Trust provided funding to Paul Coupland and Matthew Holden under grant number 098051. Biotechnology and Biological Sci- ences Research Council (BBSRC) provided funding to Janine T. Bosse, Roy R. Chaudhuri, Yanwen Li, Leon G. Leanse, Roberto Fernandez Cre- spo, Paul Coupland, Matthew Holden, Denise Mara Soares Bazzolli, Dun- can J. Maskell, Dan Tucker, Brendan W. Wren, Andrew N. Rycroft, Paul R. Langford, and BraDP1t Consortium under grant numbers BB/ G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1. Biotech- nology and Biological Sciences Research Council (BBSRC) provided funding to Paul R Langford under grant number BB/K021109/1. MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) provided funding to Denise Mara Soares Bazzolli under grant number PDE 201840/2011-1. This work was supported by a Longer and Larger (LoLa) grant from the Biotechnology and Biological Sciences Research Council (grant numbers BB/G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1), the UK Department for Environment, Food and Rural Affairs, and Zoetis (formerly Pfizer Animal Health) awarded to the Bacterial Respiratory Dis- eases of Pigs-1 Technology (BRaDP1T) consortium, a grant from Con- selho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number PDE 201840/2011-1) awarded to D.M.B., and a BBSRC Imperial-Brazil partnering award (BB/K021109/1) awarded to P.R.L. M.T.G.H. and P.C. were supported by the Wellcome Trust (grant number 098051)en
dc.description.abstractWe report here the complete annotated genome sequence of a clinical serovar 8 isolate Actinobacillus pleuropneumoniae MIDG2331. Unlike the serovar 8 reference strain 405, MIDG2331 is amenable to genetic manipulation via natural transformation as well as conjugation, making it ideal for studies of gene function.
dc.relation.ispartofGenome Announcementsen
dc.rights© 2016 Bossé et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.en
dc.subjectQH426 Geneticsen
dc.subjectR Medicineen
dc.titleComplete genome sequence of MIDG2331, a genetically tractable serovar 8 clinical isolate of Actinobacillus pleuropneumoniaeen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Infection Groupen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.description.statusPeer revieweden

This item appears in the following Collection(s)

Show simple item record